Literature DB >> 6542450

Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase II trial.

J J Kavanagh, D M Gershenson, L J Copeland, J T Wharton, F N Rutledge, I H Krakoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6542450

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  1 in total

1.  Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study.

Authors:  M A Runge-Morris; M S Kies; E Vokes; R Blough; L Weidner; R Knop; K Rowland
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.